Germany· DE-A57-71f6272305e773e7
Cefazolin Hikma
A cefazolin product containing cefazolin sodium, registered in Germany by Hikma Farmacêutica (Portugal), S.A.. The same ATC class is registered in 18 of our 19 countries.
Checked against EMA Article 57 (European Union) on
Informational only — not a medical device.
Where it is registered
Cefazolin is registered in 18 of 19 countries.
Countries holding a registration under ATC J01DB04 (cefazolin), each read from that country’s own register.
- This record: Germany, from EMA Article 57 (European Union)
- 11 of them publish a price we can compare per daily dose
Cefazolin · ATC J01DB04
18 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Spainprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of cefazolin costs, country by country.
Normalised to the WHO defined daily dose (3 g), the median price runs from $8.27 in Spain to $16.85 in Switzerland — a ×2.0 gap.
- 2 markets with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Cefazolin · price per daily dose (3 g)
USD · FX 28 Sept 2026
- CH Switzerland$16.85
- ES Spain$8.27
The record
At a glance
EMA Article 57 (European Union)- Active substance
- Cefazolin Sodium
- Manufacturer
- Hikma Farmacêutica (Portugal), S.A.
- Country
- Germany (DE)
- ATC code
- J01DB04
- ATC class
- Cefazolin
- Defined daily dose
- 3 g, P
- Reimbursed
- Not published by this register
- Source register
- EMA Article 57 (European Union)
- Last checked
- August 5, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
166 interactions on record for cefazolin.
Graded by severity as the source publishes them — 20 moderate. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cefazolin · interactions on record
166 records
- 20 moderate
- 2 minor
- 144 info
Most severe, free to view
- Sodium picosulfateA06AB08moderate
- NeomycinA07AA01moderate
- StreptomycinA07AA04moderate
- KanamycinA07AA08moderate
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cefazolin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesCefazolinWG Critical Care, LLC
- CzechiaAZEPOMedochemie Bohemia, spol. s r.o., Praha
- CanadaCEFAZOLIN FOR INJECTIONHIKMA CANADA LIMITED
- BelgiumCefazolin Hameln 1 gHameln Pharma
- SpainCEFAZOLINA LDP LABORATORIOS TORLAN 1G POLVO PARA SOLUCION INYECTABLE Y PARA PERFUSION EFGLdp Laboratorios Torlan S.A.
- SwitzerlandCefazolin Labatec
- PolandBiofazolinZakłady Farmaceutyczne POLPHARMA S.A.
- FranceCEFAZOLINE BASI 1 g, poudre pour solution injectable/pour perfusionBASI
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Cefazolin Aptapharma, Cefazolin Mip
- Belgium · Cefazoline Hameln, Cefazoline Noridem
- Bulgaria · Зепилен, Золибиотик
- Cyprus · Cefazolin Codal-Synto, Cefazolin Noridem
- Czechia · Azepo, Cefazolin Aptapharma
- Denmark · Cefazolin Mip, Cefazolin Noridem
- Estonia · Cefazolin Mip, Zepilen
- Spain · Cefazolina Iv Normon, Cefazolina Ldp-Laboratorios Torlan
- Finland · Cefazolin Mip Pharma
- France · Cefazoline Basi, Cefazoline Noridem
- United Kingdom (Northern Ireland) · Cefazolin Acs Dobfar, Cefazolin Mip Pharma
- Greece · Cefazolin Demo, Cefazolin/Demo
- Croatia · Cefazolin Alpha-Medical, Cefazolin Aptapharma
- Hungary · Cefazolin Aptapharma, Cefazolin Panpharma
- Iceland · Cefazolin Normon, Kefzol
- Italy · Cefazil, Cefazolina Git
- Lithuania · Cefazolin Mip, Rezol
- Luxembourg · Cephazolin Fresenius
- Latvia · Cefazolin Bcpp, Cefazolin Mip
- Malta · Cefazolin Medochemie, Cefazolin Pharmsol
- Netherlands · Cefazoline Hameln, Cefazoline Mylan
- Norway · Cefazolin Mip, Cefazolin Navamedic
- Poland · Biofazolin, Cefazolin Aptapharma
- Portugal · Cefazolina Basi, Cefazolina Im Hikma
- Romania · Cefazolină Aptapharma, Cefazolina Atb
- Sweden · Cefazolin Mip, Cefazolin Noridem
- Slovenia · Cefamezin, Cefazolin Aptapharma
- Slovakia · Cefazolin Aptapharma, Cefazolin Hameln
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of EMA Article 57 (European Union). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e83cfebc-bb4f-4205-862d-a64ea08d1307 GET /v1/drugs/e83cfebc-bb4f-4205-862d-a64ea08d1307?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"pzn": null,
"route": "Intramuscular Use, Intravenous Use",
"source": "ema_art57_de",
"ma_number": null,
"substance": "Cefazolin Sodium",
"atc_from_source": null,
"authorisation_country": "Germany"
}See everything about cefazolin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.